Users Stopping Slimming Jabs Regain Weight Four Times Faster Compared to Those on Conventional Diets

New research suggests that patients who discontinue popular slimming jabs like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who stop traditional diet and exercise plans.

Findings released in a prominent health publication demonstrates that while overweight people frequently drop substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month after stopping.

"People purchasing such medications must be informed of the danger of rapid rebound weight gain when the medication is stopped," warns lead investigator Dr. Susan Jebb.

This pace of regain implies a return to starting mass within about one and a half years.

Weighing Approaches

The research, which reviewed dozens of trials involving thousands of participants, contrasted the outcomes of the injectable medications with conventional dieting.

The team point out that individuals who lose weight through diet and exercise usually see a slower weight regain—perhaps 100 grams monthly—post-intervention.

The Reason for the Fast Rebound

Nutrition scientists suggest the mechanism of the jabs accounts for the heightened weight return.

GLP-1 drugs copy a body's own chemical called GLP-1, which helps regulate hunger.

"Sustained high doses of the hormone levels several times higher than normal could lead to the body to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this hormone supplement means hunger is uncontrolled, making overeating far more likely."

An Ongoing Disease?

Medical guidelines suggest the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Many experts say that, considering the likelihood of weight regain, the treatment should be considered life-long.

This opinion is reinforced by drug manufacturers, who state that the results "emphasize the persistent character of excess weight," akin to managing conditions like diabetes.

Patient Accounts

Individuals who have stopped the jabs describe a powerful resurgence of hunger.

"It was like a trigger flipping and you're instantly extremely hungry," recalled an individual.

This challenge is exacerbated if individuals have not developed permanent lifestyle or habit modifications during treatment.

Growing Adoption

Survey data suggest that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.

• Adoption is greater among females compared to males.
• The middle-aged age group shows the greatest level of interest.
• A large proportion obtain the drugs through private prescriptions rather than the NHS.

In conclusion, researchers stress that while GLP-1 drugs are potent tools for weight loss, they are not a standalone fix and maintained weight loss likely depends on integrated behavioural management.